IRB Approval Received to Develop Validated Translations of Rett Syndrome Behavioral Questionnaire into Spanish, A Key Step for Clinical Trial Initiation BOSTON, Feb. 13, 2024 /PRNewswire/ — Unravel Biosciences, Inc., (“Unravel”), an AI-enabled therapeutics company to advance drugs for…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.